Developer docs
API playgroundTry for free, no card

Search company profiles

LIMS-MBnext

Full company profile

uuid000xccq

Namestring
LIMS-MBnext
Legal namestring
Laboratoire de l'Institut Médical Spécialisé SPRL
Websiteurl
lims-mbnext.eu
Company typeenum
Private
Founded yearint
1994
Descriptiontext

LIMS-MBnext (legal entity: Laboratoire de l'Institut Médical Spécialisé SPRL, BCE 0424.567.020) is a Belgian medical analysis laboratory operating under the MBnext Europe group with three owned sites in Louvain-la-Neuve, Hornu, and Liège and approximately 180 collaborators including 8 medical biologists and pharmacist-biologists. The company runs two integrated service lines: classical clinical biology (Biologie Clinique Classique) reimbursed through INAMI, and a comprehensive Preventive Investigation Biology (BIP) portfolio of more than 30 specialized screening panels covering micronutrients, metabolic markers, genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), microbiome metagenomics, PFAS toxicology, cardiovascular, hormonal, neurological, immune, mitochondrial, and oncology support assessments, with LC-MS/MS and targeted 16S rRNA metagenomics as core analytical platforms.

The business model combines B2B2C distribution through a network of approximately 100 collection centers across Wallonia and Brussels, partner centers in France (e.g., The Health Embassy, Cabinet Infirmier Valentin Haüy), and a home-sampling collaboration with Witte Gele Kruis in Flanders backed by DHL logistics. Revenue is generated through unit-priced clinical analyses billed to INAMI (with patient co-payments), non-reimbursed preventive BIP analyses billed directly to patients via online payment, and professional services revenue through LIMS Academy training and webinars for healthcare professionals. Prescribers access results through the CyberLab real-time tracking platform and the Espace Pro portal, while the laboratory's scientific committee of 20+ clinicians (chaired by Vincenzo Castronovo, M.D., Ph.D.) underpins a community- and education-led growth motion targeted at general practitioners, specialists, naturopaths, and nutritionists in Belgium, France, and selected EU markets.

The laboratory has Belgian agrément N°8 25607 57 998, is RGPD/GDPR-compliant with a designated DPO, and is operated alongside the Limsvet veterinary diagnostics subsidiary opened at the CBTC site in November 2024, marking the group's first move into the animal health vertical. No external funding rounds, institutional investors, or IPO activity are disclosed; ownership is concentrated within the MBnext Europe corporate umbrella.

Short descriptiontext

LIMS-MBnext is a Belgian medical analysis laboratory (MBnext Europe group) operating three sites with ~180 staff, serving prescribing physicians and specialists through classical clinical biology and a 30+ panel Preventive Investigation Biology catalog delivered via a network of ~100 collection centers in Belgium and partner sites in France.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLouvain-la-neuve, Belgium
HQ citystring
Louvain-la-neuve
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical biology services, preventive medicine analysis, medical laboratory testing, functional medicine diagnostics, biological sample analysis
Industry5 codes
1Clinical Laboratory LIS (Core Lab/Hospital Lab)
CodeHLACAMAAPrimaryYes
2Public Health & Reference Lab LIMS
CodeHLACAMAFPrimaryNo
3Molecular & Genomic LIMS (NGS/Bioinformatics Lab Ops)
CodeHLACAMACPrimaryNo
4Microbiology LIS/LIMS
CodeHLACAMADPrimaryNo
5Laboratory Information Management Systems (LIMS)
CodeHLAGAJAAPrimaryNo
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Laboratory Services
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Biology Analyses
TypeSubscription Recurring
Description

Standard clinical biology analyses reimbursed by INAMI (Belgian national health insurance). The laboratory bills INAMI directly for covered analyses, with patients responsible for co-payments (ticket modérateur).

lims-mbnext.eu
2Preventive Biology Analyses
TypeOne Time License
Description

Non-INAMI reimbursed preventive and functional medicine analyses billed directly to patients. These include specialized BIP profiles, genetic polymorphism tests, microbiome analyses, and PFAS testing. Patients receive invoices and can pay online.

lims-mbnext.eu
3Professional Services and Training
TypeProfessional Services
Description

LIMS Academy provides training and webinars to healthcare professionals, generating revenue through educational programs. Dedicated services for health professionals include interpretation tools, documentation, and videotheque access.

lims-mbnext.eu
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
Pricing details2 tiers
1PFAS Analysis - Single test at 68€
ModelUnit PricingBilling cadencePay-as-you-go
Notes

PFAS analysis on blood serum at 68€ with results within 15 business days. Results include graphs and interpretations for patient exposure evaluation.

lims-mbnext.eu
2Preventive Investigation Biology (BIP) Profiles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Various BIP packages available including BIPI Intestin, BIPI Candidose, BIPI Stress, BIP Cardio, BIP Microbiote, BIP Fatigue 40+, and many others. Pricing not publicly disclosed; quote-based.

lims-mbnext.eu
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Cyberlab
Description

Real-time patient file tracking platform for healthcare professionals

lims-mbnext.eu
+4 more records
Core offering1 text field

LIMS-MBnext is a Belgian medical analysis laboratory operating three sites (Louvain-la-Neuve, Hornu, Liège) that delivers clinical biology analyses reimbursed by INAMI and a catalogue of more than 30 preventive investigation biology (BIP) panels — including intestinal, cardiovascular, hormonal, mitochondrial, neuropsychological, immune, genetic polymorphism and environmental toxicology (PFAS) assessments — to healthcare professionals who prescribe them for their patients. The laboratory supports prescribers through dedicated professional portals (CyberLab, Espace Pro), continuous education (LIMS Academy), home sampling services, and a network of partner collection centers across Belgium and France, complemented by a veterinary diagnostics subsidiary (Limsvet).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • PFAS analysis with detection limit below 0.1 µg/l for 6 PFAS compounds
+2 more records
Product overview1 text field

LIMS-MBnext is a Belgian medical analyses laboratory (approx. 180 staff, 8 medical biologists/pharmacists) operating three sites in Louvain-la-Neuve, Hornu, and Liège. The company offers two core service lines: (1) Biologie Clinique Classique covering routine clinical biology analyses, and (2) Biologie d'Investigation Préventive (BIP) — a comprehensive portfolio of over 30 specialized preventive health screening panels. The BIP portfolio includes Initial Screening panels (BIPI Intestin, BIPI Candidose, BIPI Stress, BIPI Cardio, BIP Armure Immunitaire 1.0) and Classic Preventive panels covering intestinal health (Microbiote, Dysbiose, Femibiote), metabolic and cardiovascular function (Cardio 2.0, Stéatose, Fatigue 40+, Métabolisme), hormonal and reproductive health (Fertilité, Hypothyroïdie, Métabolisme des Œstrogènes), neurological and psychological assessment (Brain, Anxiété-Dépression-Burnout, Neurotransmetteurs), genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), immune function (Typage Lymphocytaire, Armure Immunitaire 2.1), mitochondrial and oxidative stress support (Mitochondrie, Stress Oxydatif), cancer treatment accompaniment, wound healing, and environmental toxicology (PFAS). Supporting services include CyberLab real-time patient tracking, Espace Pro professional portal, LIMS Academy training, home sampling, multilingual documentation (FR/EN/NL), and logistics for international clients. A veterinary subsidiary (Limsvet) also operates from the Louvain-la-Neuve site.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International collaboration with Morocco, involving scientific exchange and laboratory services development in preventive biology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner in scientific collaboration and preventive medicine development.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Symposium and event partnership for healthcare professional education.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Collaboration with Witte Gele Kruis nurses for home blood sampling in Flanders (Eastern Flanders, Flemish Brabant, Antwerp, Limburg). Nurses collect samples, DHL transports to LIMS laboratory.

5DHL
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Transport partner for sample logistics in Flanders, collecting samples from Witte Gele Kruis locations and delivering to the laboratory.

lims-mbnext.eu
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Transport carrier for sample shipments from non-Belgian patients, particularly in France.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Veterinary analysis laboratory operated by MBnext Europe group, located at CBTC site in Louvain-la-Neuve.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Training and education partnership for healthcare professionals in nutrition and preventive medicine.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Formation and education partner in functional medicine.

10Synamief
Strategic tierMinorTypeGTM or Marketing Partner
Description

Event partner for healthcare professional congress scheduled for June 12, 2026 in Paris.

lims-mbnext.eu
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1Laboratoire Bioffice
TypeDirect peer
Description

Belgian preventive and functional medicine laboratory offering comprehensive preventive screening panels to healthcare professionals. Highly comparable in preventive biology catalog, prescriber-focused GTM, and Belgian market overlap.

TypeDirect peer
Description

Veterinary analysis laboratory operating at the same CBTC site in Louvain-la-Neuve under the MBnext Europe group. Comparable as a sister entity with shared infrastructure and similar analytical platform applied to animal diagnostics.

TypeBroad incumbent
Description

European reference laboratory group providing specialized and routine clinical diagnostics to physicians, hospitals and industry. Comparable as a European reference lab with overlapping specialty testing capabilities and physician-focused GTM.

TypeBroad incumbent
Description

Pan-European medical diagnostics leader offering routine and specialty clinical laboratory services across multiple countries. Comparable as a large-scale clinical lab competitor with broader geographic reach but less specialization in preventive/functional medicine panels.

TypeDirect peer
Description

French private medical biology laboratory group operating regional labs and collection centers. Comparable as a clinical lab serving physician prescribers via collection-center networks in neighboring France.

TypeDirect peer
Description

European specialty genetics and molecular diagnostics laboratory offering genetic testing, microbiome and molecular panels. Comparable as a specialty lab offering genetic polymorphism, microbiome, and advanced molecular testing to physicians and clinics.

TypeDirect peer
Description

France- and Belgium-based clinical laboratory network delivering routine and specialty testing through collection centers and B2B prescriber relationships. Highly comparable in business model, prescribers channel, and geographic overlap in northern France and Belgium.

8Medivere Diagnostik
TypeDirect peer
Description

German preventive diagnostics laboratory offering specialty panels in micronutrients, hormones, stool and environmental medicine. Comparable as a preventive-medicine-focused lab serving naturopaths and integrative physicians with comparable BIP-style panel offerings.

TypeDirect peer
Description

German specialty laboratory focused on preventive medicine, immunology and functional diagnostics for practitioners. Comparable as a preventive-medicine specialist lab with a physician-prescriber model and comprehensive specialty panels.

TypeBroad incumbent
Description

Major European diagnostics provider offering clinical laboratory and imaging services. Comparable as a multi-country clinical lab competitor serving physician prescribers across routine and specialty testing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LIMS-MBnext

Medical Laboratory Serviceslims-mbnext.eu

LIMS-MBnext is a Belgian medical analysis laboratory (MBnext Europe group) operating three sites with ~180 staff, serving prescribing physicians and specialists through classical clinical biology and a 30+ panel Preventive Investigation Biology catalog delivered via a network of ~100 collection centers in Belgium and partner sites in France.

What LIMS-MBnext does

LIMS-MBnext (legal entity: Laboratoire de l'Institut Médical Spécialisé SPRL, BCE 0424.567.020) is a Belgian medical analysis laboratory operating under the MBnext Europe group with three owned sites in Louvain-la-Neuve, Hornu, and Liège and approximately 180 collaborators including 8 medical biologists and pharmacist-biologists. The company runs two integrated service lines: classical clinical biology (Biologie Clinique Classique) reimbursed through INAMI, and a comprehensive Preventive Investigation Biology (BIP) portfolio of more than 30 specialized screening panels covering micronutrients, metabolic markers, genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), microbiome metagenomics, PFAS toxicology, cardiovascular, hormonal, neurological, immune, mitochondrial, and oncology support assessments, with LC-MS/MS and targeted 16S rRNA metagenomics as core analytical platforms.

The business model combines B2B2C distribution through a network of approximately 100 collection centers across Wallonia and Brussels, partner centers in France (e.g., The Health Embassy, Cabinet Infirmier Valentin Haüy), and a home-sampling collaboration with Witte Gele Kruis in Flanders backed by DHL logistics. Revenue is generated through unit-priced clinical analyses billed to INAMI (with patient co-payments), non-reimbursed preventive BIP analyses billed directly to patients via online payment, and professional services revenue through LIMS Academy training and webinars for healthcare professionals. Prescribers access results through the CyberLab real-time tracking platform and the Espace Pro portal, while the laboratory's scientific committee of 20+ clinicians (chaired by Vincenzo Castronovo, M.D., Ph.D.) underpins a community- and education-led growth motion targeted at general practitioners, specialists, naturopaths, and nutritionists in Belgium, France, and selected EU markets.

The laboratory has Belgian agrément N°8 25607 57 998, is RGPD/GDPR-compliant with a designated DPO, and is operated alongside the Limsvet veterinary diagnostics subsidiary opened at the CBTC site in November 2024, marking the group's first move into the animal health vertical. No external funding rounds, institutional investors, or IPO activity are disclosed; ownership is concentrated within the MBnext Europe corporate umbrella.

LIMS-MBnext firmographics

Firmographics
Name
LIMS-MBnext
Legal name
Laboratoire de l'Institut Médical Spécialisé SPRL
Website
https://lims-mbnext.eu
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
51–100 employees
Short description
LIMS-MBnext is a Belgian medical analysis laboratory (MBnext Europe group) operating three sites with ~180 staff, serving prescribing physicians and specialists through classical clinical biology and a 30+ panel Preventive Investigation Biology catalog delivered via a network of ~100 collection centers in Belgium and partner sites in France.
Ownership category
akta.pro rank

LIMS-MBnext industry classification

Industry
Product category
Medical Laboratory Services
NAICS
Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Clinical Laboratory LIS (Core Lab/Hospital Lab) (HLACAMAA)
akta.pro secondary industries
Public Health & Reference Lab LIMS (HLACAMAF), Molecular & Genomic LIMS (NGS/Bioinformatics Lab Ops) (HLACAMAC), Microbiology LIS/LIMS (HLACAMAD), Laboratory Information Management Systems (LIMS) (HLAGAJAA)

Keywords

  • Clinical biology services
  • Preventive medicine analysis
  • Medical laboratory testing
  • Functional medicine diagnostics
  • Biological sample analysis

Where LIMS-MBnext is headquartered

Location

Headquarters

HQ city
Louvain-la-neuve
HQ country
Belgium
HQ region
Europe

Offices3 records

Markets served

LIMS-MBnext business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical Biology Analyses: Standard clinical biology analyses reimbursed by INAMI (Belgian national health insurance). The laboratory bills INAMI directly for covered analyses, with patients responsible for co-payments (ticket modérateur).
  2. Preventive Biology Analyses: Non-INAMI reimbursed preventive and functional medicine analyses billed directly to patients. These include specialized BIP profiles, genetic polymorphism tests, microbiome analyses, and PFAS testing. Patients receive invoices and can pay online.
  3. Professional Services and Training: LIMS Academy provides training and webinars to healthcare professionals, generating revenue through educational programs. Dedicated services for health professionals include interpretation tools, documentation, and videotheque access.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPFAS Analysis - Single test at 68€
Unit PricingPay-as-you-goPreventive Investigation Biology (BIP) Profiles

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

LIMS-MBnext product offering

Product offering

Core offering

LIMS-MBnext is a Belgian medical analysis laboratory operating three sites (Louvain-la-Neuve, Hornu, Liège) that delivers clinical biology analyses reimbursed by INAMI and a catalogue of more than 30 preventive investigation biology (BIP) panels — including intestinal, cardiovascular, hormonal, mitochondrial, neuropsychological, immune, genetic polymorphism and environmental toxicology (PFAS) assessments — to healthcare professionals who prescribe them for their patients. The laboratory supports prescribers through dedicated professional portals (CyberLab, Espace Pro), continuous education (LIMS Academy), home sampling services, and a network of partner collection centers across Belgium and France, complemented by a veterinary diagnostics subsidiary (Limsvet).

Product overview

LIMS-MBnext is a Belgian medical analyses laboratory (approx. 180 staff, 8 medical biologists/pharmacists) operating three sites in Louvain-la-Neuve, Hornu, and Liège. The company offers two core service lines: (1) Biologie Clinique Classique covering routine clinical biology analyses, and (2) Biologie d'Investigation Préventive (BIP) — a comprehensive portfolio of over 30 specialized preventive health screening panels. The BIP portfolio includes Initial Screening panels (BIPI Intestin, BIPI Candidose, BIPI Stress, BIPI Cardio, BIP Armure Immunitaire 1.0) and Classic Preventive panels covering intestinal health (Microbiote, Dysbiose, Femibiote), metabolic and cardiovascular function (Cardio 2.0, Stéatose, Fatigue 40+, Métabolisme), hormonal and reproductive health (Fertilité, Hypothyroïdie, Métabolisme des Œstrogènes), neurological and psychological assessment (Brain, Anxiété-Dépression-Burnout, Neurotransmetteurs), genetic polymorphisms (FUT2, MTHFR, DIO2, APOE, COMT, LCT, AMY1A), immune function (Typage Lymphocytaire, Armure Immunitaire 2.1), mitochondrial and oxidative stress support (Mitochondrie, Stress Oxydatif), cancer treatment accompaniment, wound healing, and environmental toxicology (PFAS). Supporting services include CyberLab real-time patient tracking, Espace Pro professional portal, LIMS Academy training, home sampling, multilingual documentation (FR/EN/NL), and logistics for international clients. A veterinary subsidiary (Limsvet) also operates from the Louvain-la-Neuve site.

Differentiator

Problem solved

Functional benefit

Brands

  • Cyberlab: Real-time patient file tracking platform for healthcare professionals
  • LIMS Academy
  • Limsvet
  • BIP (Bilans d'Investigation Préventive)
  • Scientific Committee

Quantifiable outcome

  • PFAS analysis with detection limit below 0.1 µg/l for 6 PFAS compounds
  • +2 more outcomes

Companies that use LIMS-MBnext

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

LIMS-MBnext technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

LIMS-MBnext partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • GLAB (Maroc)coreStrategic or Co-development PartnerInternational collaboration with Morocco, involving scientific exchange and laboratory services development in preventive biology.
  • AlamedacoreStrategic or Co-development PartnerPartner in scientific collaboration and preventive medicine development.
  • SympminorGTM or Marketing PartnerSymposium and event partnership for healthcare professional education.
  • Witte Gele KruiscoreChannel Partner/ Reseller/ DistributorCollaboration with Witte Gele Kruis nurses for home blood sampling in Flanders (Eastern Flanders, Flemish Brabant, Antwerp, Limburg). Nurses collect samples, DHL transports to LIMS laboratory.
  • DHLcoreChannel Partner/ Reseller/ DistributorTransport partner for sample logistics in Flanders, collecting samples from Witte Gele Kruis locations and delivering to the laboratory.
  • ChronopostminorChannel Partner/ Reseller/ DistributorTransport carrier for sample shipments from non-Belgian patients, particularly in France.
  • Limsvet (Veterinary Analysis Laboratory)minorStrategic or Co-development PartnerVeterinary analysis laboratory operated by MBnext Europe group, located at CBTC site in Louvain-la-Neuve.
  • NutriHealth AcademyminorGTM or Marketing PartnerTraining and education partnership for healthcare professionals in nutrition and preventive medicine.
  • DFM FormationsminorGTM or Marketing PartnerFormation and education partner in functional medicine.
  • SynamiefminorGTM or Marketing PartnerEvent partner for healthcare professional congress scheduled for June 12, 2026 in Paris.

Scale indicators5 records

Recent moves8 records

Expansion highlights7 records

LIMS-MBnext competitors and assessment

Company assessment

Direct peers

  • Laboratoire Bioffice: Belgian preventive and functional medicine laboratory offering comprehensive preventive screening panels to healthcare professionals. Highly comparable in preventive biology catalog, prescriber-focused GTM, and Belgian market overlap.
  • Limsvet: Veterinary analysis laboratory operating at the same CBTC site in Louvain-la-Neuve under the MBnext Europe group. Comparable as a sister entity with shared infrastructure and similar analytical platform applied to animal diagnostics.
  • Inovie: French private medical biology laboratory group operating regional labs and collection centers. Comparable as a clinical lab serving physician prescribers via collection-center networks in neighboring France.
  • Eurofins Genoma Group: European specialty genetics and molecular diagnostics laboratory offering genetic testing, microbiome and molecular panels. Comparable as a specialty lab offering genetic polymorphism, microbiome, and advanced molecular testing to physicians and clinics.
  • Biogroup: France- and Belgium-based clinical laboratory network delivering routine and specialty testing through collection centers and B2B prescriber relationships. Highly comparable in business model, prescribers channel, and geographic overlap in northern France and Belgium.
  • Medivere Diagnostik: German preventive diagnostics laboratory offering specialty panels in micronutrients, hormones, stool and environmental medicine. Comparable as a preventive-medicine-focused lab serving naturopaths and integrative physicians with comparable BIP-style panel offerings.
  • GanzImmun Diagnostics: German specialty laboratory focused on preventive medicine, immunology and functional diagnostics for practitioners. Comparable as a preventive-medicine specialist lab with a physician-prescriber model and comprehensive specialty panels.

Broad incumbents

  • Cerba Healthcare: European reference laboratory group providing specialized and routine clinical diagnostics to physicians, hospitals and industry. Comparable as a European reference lab with overlapping specialty testing capabilities and physician-focused GTM.
  • Synlab: Pan-European medical diagnostics leader offering routine and specialty clinical laboratory services across multiple countries. Comparable as a large-scale clinical lab competitor with broader geographic reach but less specialization in preventive/functional medicine panels.
  • Unilabs: Major European diagnostics provider offering clinical laboratory and imaging services. Comparable as a multi-country clinical lab competitor serving physician prescribers across routine and specialty testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks4 records

Key highlights7 records

Customer concentration

LIMS-MBnext social profiles

Digital presence

LIMS-MBnext compliance and trust

Trust signal

Compliance3 records

LIMS-MBnext financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LIMS-MBnext leadership team

Management profile

Number of profiles

Profiles5 records

LIMS-MBnext subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

LIMS-MBnext funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LIMS-MBnext M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIMS-MBnext

What does LIMS-MBnext do?

LIMS-MBnext is a Belgian medical analysis laboratory operating three sites (Louvain-la-Neuve, Hornu, Liège) that delivers clinical biology analyses reimbursed by INAMI and a catalogue of more than 30 preventive investigation biology (BIP) panels — including intestinal, cardiovascular, hormonal, mitochondrial, neuropsychological, immune, genetic polymorphism and environmental toxicology (PFAS) assessments — to healthcare professionals who prescribe them for their patients. The laboratory supports prescribers through dedicated professional portals (CyberLab, Espace Pro), continuous education (LIMS Academy), home sampling services, and a network of partner collection centers across Belgium and France, complemented by a veterinary diagnostics subsidiary (Limsvet).

Is LIMS-MBnext a public or private company?

LIMS-MBnext is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LIMS-MBnext founded?

LIMS-MBnext was founded in 1994. It employs 51 to 100 people.

Where is LIMS-MBnext based?

LIMS-MBnext is headquartered in Louvain-la-neuve, Belgium, in the Europe region.

How does LIMS-MBnext make money?

Three revenue lines are on record. Clinical Biology Analyses are the primary driver. The others are preventive Biology Analyses and professional Services and Training.

Who are LIMS-MBnext's main competitors?

Direct peers on record are Laboratoire Bioffice, Limsvet, Inovie, Eurofins Genoma Group, Biogroup, Medivere Diagnostik and GanzImmun Diagnostics. Broad incumbents are Cerba Healthcare, Synlab and Unilabs.

Does LIMS-MBnext have an API?

No public API is recorded for LIMS-MBnext.

What industry is LIMS-MBnext in?

LIMS-MBnext's product category is Medical Laboratory Services. Its primary akta.pro industry code is HLACAMAA, Clinical Laboratory LIS (Core Lab/Hospital Lab), with a secondary code of HLACAMAF, Public Health & Reference Lab LIMS. Its NAICS code is 6215 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales